期刊文献+

一次接种HA DNA保护小鼠抵抗B型流感病毒攻击

A Single Inoculation of HA DNA Vaccine to Protect Mice from Influenza B Virus Attack at Lethal Dose
下载PDF
导出
摘要 为详细探讨小鼠不同次数接种B型流感病毒HA DNA疫苗后免疫应答情况,以及CpG基序的免疫佐剂效果,采用不同剂量HA DNA,1次或2次(间隔3周)电击法免疫BALB/C小鼠。初免4周后(或二免加强免疫1周后)用致死量流感病毒(B/Ibaraki/2/85)攻击。研究发现:①100μg HA DNA一次接种的小鼠全部存活;②经含有CpG基序的DNA免疫的小鼠体内诱导产生的抗HAIgG抗体更高,小鼠体重丢失更少。这些结果说明,1次接种100μg HA DNA疫苗可以使小鼠抵抗致死量B型流感病毒攻击,CpG基序能够增强HA DNA疫苗的免疫保护作用。 In order to investigate the immune response induced by different times of inoculation with influenza B virus HA DNA vaccine and the adjuvant effect of CpC motif, BALB/c mice were immunized by electrical shock once or twice at a three-week interval with plasmid HA DNA at different doses. Four week after the first immunization (or one week after the reinforced immunization), the mice were attacked with a lethal dose of influenza virus (B/ Ibaraki/2/85). The experiments showed that 1. mice immunized with a single inoculation of 100μg HA DNA all survived the lethal dose attack; 2. mice immunized with CpC-enxiehed HA-plasmids exhibited a higher amount of HA specific IgG and lower weight loss than those with HA-plasmids without CpC motif. Therefore, a single inoculation of 100μg HA DNA could provide complete protection from the lethal dose of influenza B virus attaekA DNAHA and the CpC motif could augment the immune response induced by HA DNA vaccine.
出处 《微生物学杂志》 CAS CSCD 2005年第4期4-9,共6页 Journal of Microbiology
基金 国家"863"计划(2001AA213051) 国家自然科学基金(30170043/C01010801) 国家教育部优秀青年教师基金(20001685)
关键词 流感 DNA疫苗 血凝素 CPG基序 influenza DNA vaccine hemagglutinin CpC motif HAHH
  • 相关文献

参考文献21

  • 1陈则,方芳.A、B、C三型流感病毒病毒学、流行病学、临床特征和流感疫苗[J].生命科学研究,2000,4(3):189-196. 被引量:15
  • 2Davis LE,Kornfeld M.Experimental influenza B viral myositis[J].J Neurol Sci.,2001,187(1-2):61-67.
  • 3Sazgar M,Robinson JL,Chan AK,et al.Influenza B Acute Necrotizing Encephalopathy:A Case Report and Literature Review 2002[J].Pediatr Neurol,2003,28(5):396-399.
  • 4Lin TY,Huang YC,Ning HC,et al.Surveillance of respiratory viral infections among pediatric out patients in northern Taiwan[J].J Clin Virol,2004,30(1):81-85.
  • 5Mexer HM Jr,Hopps HE,Parkman PD,et al.Review of existing vaccines for influenza[J].Am J Clin Pathol,1978,70(1 Suppl):146-152.
  • 6Chen Z,Kadowaki S,Hagiwara Y,et al.Protection against influenza B virus infection by immunization with DNA vaccines[J].Vaccine,2001,19(11-12):1 446-1 455.
  • 7Aihara H,Miyazaki J.Gene transfer into muscle by electroporation in vivo[J].Nat Biotechnol,1998,16(9):867-870.
  • 8Jeffrey L.Cleland,Single adminnistration vaccines:controlled-release technology to mimic repeated immunizations[J].Trends Biotechnol,1999,17(1):25-29.
  • 9Johnson PA,Conway MA,Daly J,et al.Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses[J].J Gen Virol,2000,81(Pt 7):1 737-1 745.
  • 10Kadowaki S,Chen Z,Asanuma H,et al.Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation[J].Vaccine,2000,18(25):2 779-2 788.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部